These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36846334)

  • 21. Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca
    Bartoli F; Bailey MA; Rode B; Mateo P; Antigny F; Bedouet K; Gerbaud P; Gosain R; Plante J; Norman K; Gomez S; Lefebvre F; Rucker-Martin C; Ainscough JFX; Kearney MT; Bruns AF; Shi J; Appleby HL; Young RS; Shawer HM; Debant M; Gomez AM; Beech DJ; Foster R; Benitah JP; Sabourin J
    Circulation; 2020 Jan; 141(3):199-216. PubMed ID: 31906693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-adrenergic-mediated dynamic augmentation of sarcolemmal Ca
    Ito DW; Hannigan KI; Ghosh D; Xu B; Del Villar SG; Xiang YK; Dickson EJ; Navedo MF; Dixon RE
    J Physiol; 2019 Apr; 597(8):2139-2162. PubMed ID: 30714156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy.
    Li Y; Zhang S; Zhang X; Li J; Ai X; Zhang L; Yu D; Ge S; Peng Y; Chen X
    Cardiovasc Res; 2014 Jul; 103(1):60-71. PubMed ID: 24812281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CaMKII inhibition in heart failure, beneficial, harmful, or both.
    Cheng J; Xu L; Lai D; Guilbert A; Lim HJ; Keskanokwong T; Wang Y
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1454-65. PubMed ID: 22287581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PDZ motif of the α1C subunit is not required for surface trafficking and adrenergic modulation of CaV1.2 channel in the heart.
    Yang L; Katchman A; Weinberg RL; Abrams J; Samad T; Wan E; Pitt GS; Marx SO
    J Biol Chem; 2015 Jan; 290(4):2166-74. PubMed ID: 25505241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of the C-terminal phosphorylation sites in the cardiac β-subunit does not affect the basic β-adrenergic response of the heart and the Ca(v)1.2 channel.
    Brandmayr J; Poomvanicha M; Domes K; Ding J; Blaich A; Wegener JW; Moosmang S; Hofmann F
    J Biol Chem; 2012 Jun; 287(27):22584-92. PubMed ID: 22589548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.
    Gresham KS; Stelzer JE
    J Physiol; 2016 Feb; 594(3):669-86. PubMed ID: 26635197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload.
    Grote-Wessels S; Baba HA; Boknik P; El-Armouche A; Fabritz L; Gillmann HJ; Kucerova D; Matus M; Müller FU; Neumann J; Schmitz M; Stümpel F; Theilmeier G; Wohlschlaeger J; Schmitz W; Kirchhefer U
    Cardiovasc Res; 2008 Aug; 79(3):464-71. PubMed ID: 18453636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15.
    Hulme JT; Lin TW; Westenbroek RE; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):13093-8. PubMed ID: 14569017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenergic regulation of the heart expressing the Ser1700A/Thr1704A mutated Cav1.2 channel.
    Poomvanicha M; Matthes J; Domes K; Patrucco E; Angermeier E; Laugwitz KL; Schneider T; Hofmann F
    J Mol Cell Cardiol; 2017 Oct; 111():10-16. PubMed ID: 28778765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.
    Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG
    Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cardiac L-type Ca²⁺ channel CaV1.2 via the β-adrenergic-cAMP-protein kinase A pathway: old dogmas, advances, and new uncertainties.
    Weiss S; Oz S; Benmocha A; Dascal N
    Circ Res; 2013 Aug; 113(5):617-31. PubMed ID: 23948586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.
    Shan J; Kushnir A; Betzenhauser MJ; Reiken S; Li J; Lehnart SE; Lindegger N; Mongillo M; Mohler PJ; Marks AR
    J Clin Invest; 2010 Dec; 120(12):4388-98. PubMed ID: 21099118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of CaV1.2 channels by cAMP-dependent protein kinase bound to A-kinase anchoring proteins 15 and 79/150.
    Fuller MD; Fu Y; Scheuer T; Catterall WA
    J Gen Physiol; 2014 Mar; 143(3):315-24. PubMed ID: 24567507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of β3-adrenergic receptor relieves pressure overload-induced cardiac hypertrophy and heart failure via enhancing innate immune response.
    Wei X; Zhang A; Yang W; Fang Y
    Biomed Pharmacother; 2021 Nov; 143():112194. PubMed ID: 34563949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional roles of a C-terminal signaling complex of CaV1 channels and A-kinase anchoring protein 15 in brain neurons.
    Marshall MR; Clark JP; Westenbroek R; Yu FH; Scheuer T; Catterall WA
    J Biol Chem; 2011 Apr; 286(14):12627-39. PubMed ID: 21224388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusion of alternative exon 33 of Ca
    Li G; Wang J; Liao P; Bartels P; Zhang H; Yu D; Liang MC; Poh KK; Yu CY; Jiang F; Yong TF; Wong YP; Hu Z; Huang H; Zhang G; Galupo MJ; Bian JS; Ponniah S; Trasti SL; See K; Foo R; Hoppe UC; Herzig S; Soong TW
    Proc Natl Acad Sci U S A; 2017 May; 114(21):E4288-E4295. PubMed ID: 28490495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoinhibitory control of the CaV1.2 channel by its proteolytically processed distal C-terminal domain.
    Hulme JT; Yarov-Yarovoy V; Lin TW; Scheuer T; Catterall WA
    J Physiol; 2006 Oct; 576(Pt 1):87-102. PubMed ID: 16809371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure.
    Guggilam A; Hutchinson KR; West TA; Kelly AP; Galantowicz ML; Davidoff AJ; Sadayappan S; Lucchesi PA
    J Mol Cell Cardiol; 2013 Apr; 57():47-58. PubMed ID: 23220155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.